Merck (MRK) earnings in Q4 2025

Merck on Tuesday reported fourth-quarter earnings and revenue that beat estimates due to strong demand for its Keytruda cancer immunotherapy…

Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…